India hasn't appealed yet, says CGF on needle controversy

Image
Press Trust of India Gold Coast
Last Updated : Apr 14 2018 | 3:55 PM IST

The Commonwealth Games Federation today said India has till now not appealed against the sending back of its two athletes from the ongoing Games here for violating the 'No Needle Policy'.

Addressing the media in his daily briefing, CGF Chief executive David Grevemberg said the suspension of race walker K T irfan and triple jumper V Rakesh Babu has not been challenged till now despite the Indian contingent's claims of pushing for an appeal.

"I have not received an appeal, and such an appeal would go through the Court of Arbitration, Court of Sport. Regardless of the needle, there is a no needle policy. There is a clear policy, there was a breach of that policy and this isn't an isolated case (involving India), as we all know," Grevemberg said when asked about further developments in the matter.

A source in the Indian contingent added the country has indeed not yet appealed and is weighing its legal options before taking such a step.

"The recommendation is for an appeal but we have to seek proper legal opinion before going ahead with it. It can't be rushed otherwise it will fall apart," an official told PTI.

Irfan and Babu were sent home last night after their explanation for having syringe in their room was declared "evasive and unreliable" by the CGF court.

The Athletics Federation of India has formed a panel to investigate the matter and promised to take severe action against the two if found guilty after the investigation.

Irfan and Babu's CWG campaign had ended before they were asked to leave the Games. While Irfan had finished 13th in the 20km race walk, Babu had injured his knee during the triple jump qualifiers to be ruled out of the finals.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 14 2018 | 3:55 PM IST

Next Story